ZIMMER BIOMET HLDGS 15/35ZIMMER BIOMET HLDGS 15/35ZIMMER BIOMET HLDGS 15/35

ZIMMER BIOMET HLDGS 15/35

No trades
See on Supercharts

ZIMC analysis



Key facts


Issue date
Mar 19, 2015
Maturity date
Aug 15, 2035
Outstanding amount
‪253.42 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
4.25% (Fixed)
Yield to maturity
5.44%
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.